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Introduction
 Breast cancer is the most common cancer and the most 
common cause of death from cancer in women worldwide. 
The incidence rate of breast cancer is highest in North 
America with the age standardized rates of 99.4 per 
100,000 population, followed by countries in the Eastern 
Europe, South America, Southern Africa, and western Asia 
with moderate incidence rates, while the lowest incidence 
rates are reported in most African countries (WHO, 2010). 
Globally, breast cancer incidence is rising but mortality is 
declining in high income countries due to earlier detection 
and more effective therapy. Incidence and mortality rates 
tend to be higher in high-resource countries compared to 
low-resource countries (Smith, 2006). However, in low-
resource countries fatality rates tend to be higher (Parkin 
et al., 2005). 
 According to the World Health Organization (WHO) 
70% of cancer deaths in 2005 occurred in low- and 
middle-income countries. In addition to that, the rising 
incidence in developing countries is worsened by the fact 
that majority of the cases present in the late stage ((WHO, 
2010). Rising breast cancer incidence in developing 
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Abstract
 Breast cancer is the most common cancer in Malaysian females. The National Cancer Registry in 2003 and 
2006 reported that the age standardized incidence of breast cancer was 46.2 and 39.3 per 100,000 populations, 
respectively.  With the cumulative risk at 5.0; a woman in Malaysia had a 1 in 20 chance of developing breast 
cancer in her lifetime. The incidence of cancer in general, and for breast cancer specifically was highest in the 
Chinese, followed by Indians and Malays. Most of the patients with breast cancers presented at late stages (stage 
I: 15.45%, stage II:  46.9%, stage III:  22.2% and stage IV: 15.5%). The Healthy Lifestyles Campaign which 
started in the early nineties had created awareness on breast cancer and after a decade the effort was enhanced 
with the Breast Health Awareness program to promote breast self examination (BSE) to all women, to perform 
annual clinical breast examination (CBE) on women above 40 and mammogram on women above 50. The National 
Health Morbidity Survey in 2006 showed that the prevalence rate of 70.35% by any of three methods of breast 
screening; 57.1% by BSE, 51.8% by CBE and 7.6% by mammogram. The current screening policy for breast 
cancer focuses on CBE whereby all women at the age of 20 years and above must undergo breast examination 
by trained health care providers every 3 years for age between 20-39 years, and annually for age 40 and above. 
Several breast cancer preventive programs had been developed by various ministries in Malaysia; among which 
are the RM50 subsidy for mammogram by the Ministry of Women, Family and Community Development and 
the SIPPS program (a call-recall system for women to do PAP smear and CBE) by the Ministry of Health. 
Measures to increase uptake of breast cancer screening and factors as to why women with breast cancer present 
late should be studied to assist in more development of policy on the prevention of breast cancer in Malaysia. 
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countries is due to urbanization, ageing population and 
lifestyle changes.
 Many efforts had been implemented to improve breast 
health in Malaysia. However the situation is still worrying 
whereby the number of advanced breast cancer although 
reduced from previous years, it is still higher than its 
neighboring countries. The aim of this paper is to look 
into the breast cancer screening policies in Malaysia, in 
particular the breast screening policies and to discuss the 
breast cancer screening activities in Malaysia.
 
Breast Cancer in Malaysia
 Breast cancer is the commonest cancer among 
Malaysian women in all ethnic groups (Lim and Halimah, 
2008). A woman in Malaysia has 1 in 20 chance of getting 
a breast cancer in her lifetime. According to the National 
Cancer Registry, the Age Standardized Rate (ASR) of 
female breast cancer in Malaysia is 47.4 per 100,000 
populations in 2003 to 2005 and this dropped to 39.3 in 
2006 (Zainal and Nor Saleha, 2006). However, the ASR is 
higher than those in other Asian countries (Beijing, 24.6, 
Hiroshima 36.6, Chennai 23.9 and Seoul 20.8), (Lim and 
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Halimah, 2008). There are variations in the incidence rates 
of breast cancer among the three main ethnic groups in 
Malaysia. Amongst the Chinese, the ASR is highest at 
59.9 per 100,000 population, for the Indians, the ASR is 
54.2 per 100,000 and it is lowest in the Malays at 34.9 per 
100,000 population. Breast cancer accounted for 31.3% 
of the total number of the new cases in women (Lim and 
Halimah, 2008). These differences may be attributed to 
the differences in lifestyle, diet and reproductive behavior 
namely those that relates to childbearing and breastfeeding 
practices.
 According to the Third National Cancer Registry 
Report 2008, the peak incidence for breast cancer is 
between the ages of 50 to 60 years of age except for Indians 
where the peak is after the age of 60 years old. 
 Generally, Malaysian women presents at later stages 
of breast cancer compared to other counterparts in the 
developing countries whereby 30-40% present at stage 3 
to stage 4 involving mostly the Malays resulting poorer 
outcome compared to other ethnicities (Yip and Ibrahim, 
2006). They reported the commonest presenting symptom 
was a lump in the breast (90%) and the mean size of the 
lump is 4.2cm. 
International Breast Cancer Screening Policy 
 BThere have been ongoing discussions and 
recommendations made regarding breast cancer screening 
strategies in different countries around the world. These 
strategies or policies differ in terms of the methods 
chosen or the way they are implemented based on the 
current evidences on screening practices and availability 
of resources. Among the characteristics of breast cancer 
screening programs surveyed in the International Cancer 
Screening Network (ICSN, 2002) in the participating 
countries are the program type (national, state, provincial 
or regional), detection methods used (that is either using 
screening mammography, clinical breast examination or 
breast self examination or combination of any of those 
methods), the age groups covered by mammography and 
the screening intervals adopted in each country (Shapiro, 
1998; ICSN, 2002). However, the ICSN is participated 
only by countries with population based cancer screening 
programs and these are mainly the developed countries. 
 As for the lower and middle income countries, the 
Breast Health Global Initiative (BHGI) has developed 
some evidence based recommendations for countries 
with limited resources whereby the method of breast 
screening for early detections depends on the available 
resources. The availability of resources were divided 
into four levels namely basic, limited, enhanced and 
maximal (Smith, 2006). It was also stressed that women 
should receive full support to seek, have access to health 
care and that all women should be promoted regarding 
breast health awareness. The Early Detection and Access 
to Care Panel recommended that the method of early 
screening for breast cancer can be enhanced once the 
resource is available from as basic as promoting breast 
health awareness to training of health care staff on clinical 
breast examination, opportunistic CBE screening, trials of 
organized screenings using CBE or breast self examination 
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and feasibility studies of population based mammographic 
screenings (Smith, 2006)
 
Breast Cancer Screening Policy in Malaysia
In the planning for breast cancer prevention programs, 
the Ministry of Health is approaching the issue by looking 
into both primary and secondary prevention of breast 
cancer. The primary prevention includes increasing 
breast health awareness and promoting healthy lifestyle 
and lifestyle modification while secondary prevention 
includes early diagnosis and early treatment to prevent 
from complications (Figure 1).
In terms of breast cancer screening policies, currently 
Malaysia is practicing opportunistic screening for 
breast cancer. There are three main activities for breast 
cancer screening in Malaysia. They are Breast Self 
Awareness (BSA) or previously known as Breast Self 
Examination (BSE), Clinical Breast Examination (CBE) 
and mammography screening. The Ministry of Health 
has been promoting Breast Self Examination (BSE) and 
annual breast examination by trained health workers as 
part of breast cancer awareness campaign since 1995.
According to the Third National Health Morbidity 
Survey (NHMS, 2006), the prevalence rate for breast 
examination in Malaysia was 70.35% where the highest 
was for BSE (57.14%), followed by CBE (51.77%) while 
for mammography it was 7.57%. The prevalence rate for 
breast examination was higher for the age group between 
30-34 years old (82.04%) (9). This still shows that breast 
screening facilities in Malaysia is still underutilized, 
especially by the target groups although it has improved 
compared to the figures in the Second NHMS in 1996.
Screening targets women attending the women’s 
wellness clinics, maternal and child health clinics and lately 
also offered to women attending the outpatient clinics in 
the Ministry of Health (MOH) facilities. Clinical breast 
examination were offered to those women who came for 
PAP smear screening while breast self awareness (BSA) 
are being taught at the time of contact for some women. In 
Malaysia, currently health care workers in health clinics 
are no longer routinely teaching women on breast self 
examination but are available if requested by the client 
and the women would be made aware of its limitations. 
This is due to evidences that showed that BSE could not 
be recommended as a screening tool for breast cancer 
based on 3 large trials in the United Kingdom, Shanghai 
and Russia (Kosters, 2003). Instead they are encouraged 
to teach women on breast self awareness whenever they 
are in contact with the women. The Ministry of Health 
(MOH), Malaysia recommends three simple steps that 
are easy for public health education which are Look for 
any breast changes, Feel for any lumps and Response by 
reporting any changes at the nearest clinic as part of the 
Breast Self Awareness (BSA) activities.
The current screening policy recommended by the 
Ministry of Health on breast cancer includes encouraging 
breast self examination in all women as breast awareness 
promotion program and also focuses on clinical breast 
examination whereby for all women above the age 
of 20 years up to 39 years, they are encouraged to 
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undergo clinical breast examination by trained health 
care providers every three years while for those above 
the age of 40 years and those with high risks of getting 
breast cancer regardless of the age should have annual 
clinical breast examination (KKM, 2002). In addition to 
that, women identified as high risk will be appropriately 
managed according to age and other factors, based on the 
existing Clinical Practice Guidelines on the Management 
of Breast Cancer (MOH, 2006).
Mammogram is another radiological or imaging 
modality for early detection of breast cancer. In Malaysia, 
mammography is being indicated to women in the ‘high 
risk’ group as indicated in the Clinical Practice Guidelines 
(CPG). These are women with a history of breast atypia on 
previous breast biopsy, history of cancer in one breast and/
or ovarian cancer and also women with a family history 
of breast cancer in one or more of first or second degree 
relatives (mother and sisters) before the age of 50 years.
Mammography may also be considered for those 
under the age of forty at the discretion of the doctor and 
if the patient wishes to do so (MOH, 2006). Mammogram 
is done free of charge in government facilities for those 
who are ‘eligible’ (‘high risk’). Mammography screenings 
are also available in the private centers for any women 
including those who are not high risks and may cost 
between RM 100 to RM 120.
To further promote greater awareness among women 
to undergo mammogram screening for early detection 
of breast cancer, the Ministry Of Women, Family and 
Community Development (MWFC) in the year 2007 
provide a RM50 subsidy for every mammogram done in 
private clinics and hospitals registered with the National 
Population and Family Development Board Malaysia 
(NPFDB) or better known as Lembaga Penduduk dan 
Pembangunan Keluarga Negara Malaysia (LPPKN). 
However this service is only available to women who 
met the eligibility criteria which includes women with 
high risk of breast cancer with monthly household income 
below RM 5,000. So far, 18,000 women were screened 
through this program,  whereby 63 women (0.36 percent) 
were positive for breast cancer, while 1,543 women (8.9 
percent) went for further investigation for breast cancer 
(13).
There are also efforts to combine screening programs 
for the two most common cancers in Malaysia among 
women. These are breast cancers followed by cervical 
cancers where the age standardized incidence rates (ASR) 
are 47.3 and 16.1 per 100,000 populations respectively 
(4).  Currently the government health clinics in Malaysia 
are offering cancer screenings for these two cancers to 
women who utilized these health facilities with a highly 
subsidized health services at a very low cost i.e RM 1. 
There are two districts chosen by the MOH which are 
the Klang (urban) and the Mersing (rural) districts for a 
pilot study known as SIPPS (Sistem Informasi Program 
Pap Smear). The SIPPS programme is a call-recall pilot 
study for population based PAP smear screening. Women 
who attended will have their CBE done at the same time 
as their pap smears were taken. This will benefit more 
women in terms of early detection of the two common 
cancers. However the cost effectiveness of this strategy 
as a population based screening program has yet to be 
ascertained as this study is still ongoing. 
Despite health education efforts to educate women on 
breast health awareness including the awareness on the 
different screening modalities available, the incidence of 
breast cancer and presentation at an advanced stage is still 
a problem in Malaysia. This has led the MOH into revising 
Malaysia’s policy on breast cancer and also into looking 
at the possibility of expanding mammogram to a wider 
group of women. However, population-based screening 
mammography is not recommended in Malaysia due to 
limited resources as well as the lack of local statistics on 
mammography and breast cancer. 
Delay in Diagnosis Of Breast Cancer 
There are two types of delay in breast cancer that 
are patient delay and provider delay (Karla, 2009).The 
former is usually defined as the period between discovery 
of symptom by the patient to the initial contact with a 
physician and the latter is from the initial contact of the 
physician and the beginning of definitive treatment. Total 
delay in breast cancer presentation is usually defined as 
more than three months from symptom discovery by the 
patient and the beginning of medical treatment. 
Previous studies have shown that Malaysian women 
presents at an advanced stage at diagnosis of breast cancer 
with a larger tumour size as compared to other countries 
in the western region. In a study by Hisham and Yip 
(2003), involving two hospitals in an urban area namely 
Hospital Kuala Lumpur and University Malaya Medical 
Centre (UMMC), there were 50% to 60% and 30% to 
40% of women respectively, whom presented at late stage 
at diagnosis (stage 3 and stage 4) whereby the median 
duration of symptoms before presenting was 3 months . 
The majority was of Malay ethnicy and the average tumour 
size was reported to be 5.4cm and 4.2cm respectively. 
The delay in presentation of breast cancer can be 
attributed to many reasons where mostly they are related 
to the socio-cultural issues. According to Benjamin et al. 
(2007), in Sabah, presentation at advanced disease were 
associated with being a non-Chinese race, patients from 
rural area, those with income of less than 1000 RM per 
month and the non-educated. It was also reported that 
the majority of those who defaulted treatment opted for 
Figure 1. Breast Cancer Prevention Programs (Source: 
Breast Cancer Prevention and Control, Family Health 
Development Division, 2007
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